Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update
- PMID: 33854473
- PMCID: PMC8039296
- DOI: 10.3389/fneur.2021.630221
Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update
Abstract
Meige syndrome (MS) is cranial dystonia characterized by the combination of upper and lower cranial involvement and including binocular eyelid spasms (blepharospasm; BSP) and involuntary movements of the jaw muscles (oromandibular dystonia; OMD). The etiology and pathogenesis of this disorder of the extrapyramidal system are not well-understood. Neurologic and ophthalmic examinations often reveal no abnormalities, making diagnosis difficult and often resulting in misdiagnosis. A small proportion of patients have a family history of the disease, but to date no causative genes have been identified to date and no cure is available, although botulinum toxin A therapy effectively mitigates the symptoms and deep brain stimulation is gaining increasing attention as a viable alternative treatment option. Here we review the history and progress of research on MS, BSP, and OMD, as well as the etiology, pathology, diagnosis, and treatment.
Keywords: Meige syndrome; blepharospasm; oromandibular dystonia; pathogenic gene; variants.
Copyright © 2021 Ma, Qu, Ye, Shu and Qu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol. (1998) 78:1–10. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
